Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2575 USD | +3.00% |
|
+0.98% | -98.29% |
06-12 | Motion for Asset Sale Approved for Acorda Therapeutics, Inc. | CI |
05-14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 0.5100 | 2.071 | 2.060 |
Spread/Res. | -49.51% | -87.57% | -87.50% |
Spread/Supp. | +5.10% | +5.10% | +3.00% |
Support | 0.2450 | 0.2450 | 0.2500 |
- Stock Market
- Equities
- ACOR.Q Stock
- ACOR Stock
- Charts Acorda Therapeutics, Inc.